Anne Wojcicki, co-founder of 23andMe, has filed to take the genetic testing firm private by offering to purchase all shares for 40 cents per share. The proposal, previously hinted at by Wojcicki, was made public in a filing with the Securities and Exchange Commission. The deal would need approval from a special committee of 23andMe’s board and its shareholders. Wojcicki expressed excitement about the firm’s mission of improving global health through genetics and emphasized their valuable brand and diverse genetic dataset. She remains committed to the vision of becoming a global leader in genetics and integrating it into healthcare worldwide.
Source link
23andMe co-founder Anne Wojcicki files proposal to take company private
